Participation to IMMUNOSHAPE

GLYcoDiag is pleased to announce his participation to the Marie Skłodowska- Curie

Innovative Training Networks (ITN-ETN) entiled “IMMUNOSHAPE“. 

Focused on the “development of selective caImmunoshaperbohydrate immunomodulators targeting C-type lectin receptors on antigen presenting cells“, this project aims to train future researchers that will be capable of combining state of the art synthesis and screening technology to develop new lead structures for highly selective glycan based multivalent immunotherapeutics for the treatment of cancer, autoimmune diseases and allergy. The consortium, composed of nine academic groups with expertise in automated solid-phase carbohydrate synthesis, microarray based highthroughput screening technology, tumour immunology, structural glycobiology, multivalent systems and medicinal chemistry along with four industrial partners active in nanomedicine, immunotherapy, medicinal device development and the fabrication of scientific instrumentation, will provide a multidisciplinary and multisectorial training to 15 ESRs in biomedical glycoscience and its industrial applications.This project has been awarded a €3.8 million European Union grant intended at the recruitment of early stage researchers, them training and the management of the research activities for each specific tasks described for each beneficiaries of the program.